1. B.V. Genzyme Europe,European Public Assesment Report Evoltra – EMEA/H/C/000613 – S/0045. (16.03.2015).
2. Clofarabine (2-chloro-2′-fluoro-2′-deoxyarabinosyladenine)—biochemical aspects of anticancer activity;Majda;Acta Pol. Pharm.,2011
3. Deoxynucleotide pool depletion and sustained inhibition of ribonucleotide reductase and DNA synthesis after treatment of human lymphoblastoid cells with 2-chloro-(2-deoxy- fluoro-β-D-arabinofuranosyl) adenine;Xie;Cancer Res.,1996
4. Metabolism and actions of 2-Chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)-adenine in human lymphoblastoid cells;Xie;Cancer Res.,1995
5. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2 '-arabino-fluoro-2'-deoxyadenosine;Carson;Proc. Natl. Acad. Sci. U. S. A.,1992